Heartflow Inc. (HTFL) exhibits 76.8% gross margins and -12.0% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.
Sustained 76.8% gross profitability converts into -36.4% operating margin and -12.0% ROIC, outpacing sector cost of capital.
ROIC: -12.0% // GM: 76.8%YoY revenue trajectory of +39.9% paired with -1.12% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +39.9% // FCF YLD: -1.12%Altman Z-Score of 26.00 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 26.00 // F-SCORE: 5/9Trading at 24.0x trailing P/E (27.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $59.05 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend -60.0% net margins.
NET MARGIN: -60.0% // D/E: 0.08x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for HTFL & activate live FRED threshold breach alerts.